Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Gardoni

Showing results (21-30 of 139) with videos related to

Pageof 14
Sort By:
The Journal of Biological Chemistry|March 27, 2004
Calcium/calmodulin-dependent protein kinase II phosphorylation drives synapse-associated protein 97 into spinesDaniela Mauceri, Flaminio Cattabeni, Monica Di Luca, et al.
Progress in Brain Research|August 11, 2010
Assemblies of glutamate receptor subunits with post-synaptic density proteins and their alterations in Parkinson's diseaseFabrizio Gardoni, Veronica Ghiglieri, Monica Di Luca, et al.
Neuro-Degenerative Diseases|September 7, 2013
ADAM10 in synaptic physiology and pathologyStefano Musardo, Elena Marcello, Fabrizio Gardoni, et al.
The Journal of Biological Chemistry|January 27, 2010
An arginine stretch limits ADAM10 exit from the endoplasmic reticulumElena Marcello, Fabrizio Gardoni, Monica Di Luca, et al.
Journal of Experimental Pharmacology|April 1, 2021
Experimental Disease-Modifying Agents for Frontotemporal Lobar DegenerationMarcello Giunta, Eino Solje, Fabrizio Gardoni, et al.
Neurobiology of Disease|February 15, 2025
Long-term exposure to anti-GluA3 antibodies triggers functional and structural changes in hippocampal neuronsMaria Italia, Alessio Spinola, Barbara Borroni, et al.
Pharmacological Research|September 6, 2020
Protease-activated receptor 1 (PAR1) inhibits synaptic NMDARs in mouse nigral dopaminergic neuronsRachel Price, Elena Ferrari, Fabrizio Gardoni, et al.
The Journal of Biological Chemistry|March 21, 2003
Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptorsChiara Fiorentini, Fabrizio Gardoni, PierFranco Spano, et al.
Expert Opinion on Therapeutic Targets|September 30, 2017
ADAM10 as a therapeutic target for brain diseases: from developmental disorders to Alzheimer's diseaseElena Marcello, Barbara Borroni, Silvia Pelucchi, et al.
International Journal of Molecular Sciences|March 29, 2023
Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19Maria Mancini, Silvia Natoli, Fabrizio Gardoni, et al.
Pageof 14

Showing results (21-30 of 139) with videos related to

Sort By:
Pageof 14
The Journal of Biological Chemistry|March 27, 2004
Calcium/calmodulin-dependent protein kinase II phosphorylation drives synapse-associated protein 97 into spinesDaniela Mauceri, Flaminio Cattabeni, Monica Di Luca, et al.
Progress in Brain Research|August 11, 2010
Assemblies of glutamate receptor subunits with post-synaptic density proteins and their alterations in Parkinson's diseaseFabrizio Gardoni, Veronica Ghiglieri, Monica Di Luca, et al.
Neuro-Degenerative Diseases|September 7, 2013
ADAM10 in synaptic physiology and pathologyStefano Musardo, Elena Marcello, Fabrizio Gardoni, et al.
The Journal of Biological Chemistry|January 27, 2010
An arginine stretch limits ADAM10 exit from the endoplasmic reticulumElena Marcello, Fabrizio Gardoni, Monica Di Luca, et al.
Journal of Experimental Pharmacology|April 1, 2021
Experimental Disease-Modifying Agents for Frontotemporal Lobar DegenerationMarcello Giunta, Eino Solje, Fabrizio Gardoni, et al.
Neurobiology of Disease|February 15, 2025
Long-term exposure to anti-GluA3 antibodies triggers functional and structural changes in hippocampal neuronsMaria Italia, Alessio Spinola, Barbara Borroni, et al.
Pharmacological Research|September 6, 2020
Protease-activated receptor 1 (PAR1) inhibits synaptic NMDARs in mouse nigral dopaminergic neuronsRachel Price, Elena Ferrari, Fabrizio Gardoni, et al.
The Journal of Biological Chemistry|March 21, 2003
Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptorsChiara Fiorentini, Fabrizio Gardoni, PierFranco Spano, et al.
Expert Opinion on Therapeutic Targets|September 30, 2017
ADAM10 as a therapeutic target for brain diseases: from developmental disorders to Alzheimer's diseaseElena Marcello, Barbara Borroni, Silvia Pelucchi, et al.
International Journal of Molecular Sciences|March 29, 2023
Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19Maria Mancini, Silvia Natoli, Fabrizio Gardoni, et al.
Pageof 14